Intravenous immunoglobulin therapy in proximal diabetic neuropathy

Keyphrases

• Intravenous Immunoglobulin Therapy 100%
• Diabetic Neuropathy 100%
• Severe Pain 66%
• Muscle Strength 66%
• Intravenous Immunoglobulin (IVIg) 66%
• Visual Analog Scale 33%
• Older Men 33%
• Muscle Weakness 33%
• Clinical Features 33%
• Lower Extremity 33%
• Type 2 Diabetes Mellitus (T2DM) 33%
• Wheelchair 33%
• Muscle Atrophy 33%
• Cane 33%
• Leg Pain 33%
• Pain Relief 33%
• Electrophysiological Characteristics 33%
• Massive Weight Loss 33%
• Leg muscles 33%

Medicine and Dentistry

• Intravenous Immunoglobulin Therapy 100%
• Diabetic Neuropathy 100%
• Muscle Strength 66%
• Visual Analog Scale 33%
• Leg 33%
• Maturity Onset Diabetes of the Young 33%
• Muscle Weakness 33%
• Muscle Atrophy 33%
• Leg Pain 33%
• Leg Muscle 33%
• Assistive Cane 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Immunotherapy 100%
• Diabetic Neuropathy 100%
• Non Insulin Dependent Diabetes Mellitus 33%
• Muscle Atrophy 33%
• Muscle Weakness 33%
• Leg Pain 33%